Business Context and Reporting Period
This Form 8-K filing by Minerva Neurosciences, Inc. (NERV) reports the results of the Annual Meeting of Stockholders held on May 31, 2019, in Boston, Massachusetts. The company is incorporated in Delaware and trades on The Nasdaq Global Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following matters were submitted to a vote of security holders:
- Proposal 1: Election of Directors
- Dr. Remy Luthringer: Elected with 26,984,995 votes for, 3,247,722 withheld, and 4,217,005 broker non-votes.
- Dr. Fouzia Laghrissi-Thode: Elected with 26,777,767 votes for, 3,454,950 withheld, and 4,217,005 broker non-votes.
- Jeryl Lynn Hilleman: Elected with 30,022,264 votes for, 210,453 withheld, and 4,217,005 broker non-votes.
- All three nominees were elected to serve until the 2022 annual meeting.
- Proposal 2: Ratification of Independent Auditor
- Deloitte & Touche LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2019.
- Votes: 34,411,936 For, 31,712 Against, 6,074 Abstain.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the total number of shares outstanding to contextualize the voting percentages.
- Confirm the tenure and background of the newly elected directors (Dr. Luthringer, Dr. Laghrissi-Thode, and Ms. Hilleman).
- Review the full proxy statement for details on the rationale behind the auditor selection and director nominations.